ANGIODYNAMICS INC — Director's Dealing 2022

Jul 11, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2022-07-07

Reporting Person: Clemmer James C (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-07-07	Common Stock	M	25123	—	Acquired	415887	Direct
2022-07-07	Common Stock	F	8574	$20.54	Disposed	407313	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-07-07	Performance Right	$	M	50139	Disposed		Common Stock (50139)	Direct

Footnotes

F1: This acquisition of 25,123 shares of common stock ("Common Stock") of AngioDynamics, Inc. (the "Company") represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on October 16, 2019

F2: The exempt disposition of 8,574 shares of Common Stock to the Company was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on October 16, 2019.

F3: On October 16, 2019, the reporting person received a target grant of 50,139 performance share units. Between 0% and 200% of the target number was to be earned based equally on revenue growth and adjusted earnings per share growth over a three-year performance period with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate). Based on performance over the period, 25,123 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited.